These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12660860)

  • 1. Estimating the burden and economic impact of trachomatous visual loss.
    Frick KD; Basilion EV; Hanson CL; Colchero MA
    Ophthalmic Epidemiol; 2003 Apr; 10(2):121-32. PubMed ID: 12660860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global burden of trachomatous visual impairment: II. Assessing burden.
    Evans TG; Ranson MK
    Int Ophthalmol; 1995-1996; 19(5):271-80. PubMed ID: 8864810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global burden of trachoma and economics of the disease.
    Frick KD; Hanson CL; Jacobson GA
    Am J Trop Med Hyg; 2003 Nov; 69(5 Suppl):1-10. PubMed ID: 14692674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Simple Method for Estimating the Economic Cost of Productivity Loss Due to Blindness and Moderate to Severe Visual Impairment.
    Eckert KA; Carter MJ; Lansingh VC; Wilson DA; Furtado JM; Frick KD; Resnikoff S
    Ophthalmic Epidemiol; 2015; 22(5):349-55. PubMed ID: 26395661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Economic Impact of Blindness in Europe.
    Chakravarthy U; Biundo E; Saka RO; Fasser C; Bourne R; Little JA
    Ophthalmic Epidemiol; 2017 Aug; 24(4):239-247. PubMed ID: 28665742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Lost Productivity Resulting from the Global Burden of Myopia: Systematic Review, Meta-analysis, and Modeling.
    Naidoo KS; Fricke TR; Frick KD; Jong M; Naduvilath TJ; Resnikoff S; Sankaridurg P
    Ophthalmology; 2019 Mar; 126(3):338-346. PubMed ID: 30342076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global burden of trachomatous visual impairment: I. Assessing prevalence.
    Ranson MK; Evans TG
    Int Ophthalmol; 1995-1996; 19(5):261-70. PubMed ID: 8864809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia.
    Frick KD; Joy SM; Wilson DA; Naidoo KS; Holden BA
    Ophthalmology; 2015 Aug; 122(8):1706-10. PubMed ID: 26190438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global burden of trachoma: a review.
    Burton MJ; Mabey DC
    PLoS Negl Trop Dis; 2009 Oct; 3(10):e460. PubMed ID: 19859534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of blindness and visual impairment in Germany from a societal perspective: a cost-of-illness study.
    Chuvarayan Y; Finger RP; Köberlein-Neu J
    Eur J Health Econ; 2020 Feb; 21(1):115-127. PubMed ID: 31493181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic cost of visual impairment in Japan.
    Roberts CB; Hiratsuka Y; Yamada M; Pezzullo ML; Yates K; Takano S; Miyake K; Taylor HR
    Arch Ophthalmol; 2010 Jun; 128(6):766-71. PubMed ID: 20547955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis.
    Wang EY; Kong X; Wolle M; Gasquet N; Ssekasanvu J; Mariotti SP; Bourne R; Taylor H; Resnikoff S; West S
    Ophthalmology; 2023 Aug; 130(8):863-871. PubMed ID: 36963570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact of visual impairment and blindness in the United States.
    Frick KD; Gower EW; Kempen JH; Wolff JL
    Arch Ophthalmol; 2007 Apr; 125(4):544-50. PubMed ID: 17420375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma.
    Evans TG; Ranson MK; Kyaw TA; Ko CK
    Br J Ophthalmol; 1996 Oct; 80(10):880-9. PubMed ID: 8976698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resource allocation to prevent trachomatous low vision among older individuals in rural areas of less developed countries.
    Frick KD; Mecaskey JW
    Doc Ophthalmol; 2002 Jul; 105(1):1-21. PubMed ID: 12152798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic impact of sight loss and blindness in the UK adult population.
    Pezzullo L; Streatfeild J; Simkiss P; Shickle D
    BMC Health Serv Res; 2018 Jan; 18(1):63. PubMed ID: 29382329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trachoma, cataracts and uncorrected refractive error are still important contributors to visual morbidity in two remote indigenous communities of the Northern Territory, Australia.
    Wright HR; Keeffe JE; Taylor HR
    Clin Exp Ophthalmol; 2009 Aug; 37(6):550-7. PubMed ID: 19702703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The magnitude and cost of global blindness: an increasing problem that can be alleviated.
    Frick KD; Foster A
    Am J Ophthalmol; 2003 Apr; 135(4):471-6. PubMed ID: 12654362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global burden of visual impairment and blindness.
    Bourne R; Price H; Stevens G;
    Arch Ophthalmol; 2012 May; 130(5):645-7. PubMed ID: 22652851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.